166 related articles for article (PubMed ID: 32011449)
1. Non-diabetic end-stage renal disease in Saudis associated with polymorphism of MYH9 gene but not UMOD gene.
Adam KM; Mohammed AM; Elamin AA
Medicine (Baltimore); 2020 Jan; 99(3):e18722. PubMed ID: 32011449
[TBL] [Abstract][Full Text] [Related]
2. UMOD as a susceptibility gene for end-stage renal disease.
Reznichenko A; Böger CA; Snieder H; van den Born J; de Borst MH; Damman J; van Dijk MC; van Goor H; Hepkema BG; Hillebrands JL; Leuvenink HG; Niesing J; Bakker SJ; Seelen M; Navis G;
BMC Med Genet; 2012 Sep; 13():78. PubMed ID: 22947327
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
[TBL] [Abstract][Full Text] [Related]
4. A single nucleotide polymorphism in the UMOD promoter is associated with end stage renal disease.
Chen T; Wang Q; Li G; Wang L
BMC Med Genet; 2016 Dec; 17(1):95. PubMed ID: 27938332
[TBL] [Abstract][Full Text] [Related]
5. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
[TBL] [Abstract][Full Text] [Related]
6. Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations.
Cyrus C; Al-Mueilo S; Vatte C; Chathoth S; Li YR; Qutub H; Al Ali R; Al-Muhanna F; Lanktree MB; Alkharsah KR; Al-Rubaish A; Kim-Mozeleski B; Keating B; Al Ali A
BMC Nephrol; 2018 Apr; 19(1):88. PubMed ID: 29665793
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa.
Matsha TE; Masconi K; Yako YY; Hassan MS; Macharia M; Erasmus RT; Kengne AP
PLoS One; 2012; 7(12):e52529. PubMed ID: 23285077
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
[TBL] [Abstract][Full Text] [Related]
10. The MYH9/APOL1 region and chronic kidney disease in European-Americans.
O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH
Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915
[TBL] [Abstract][Full Text] [Related]
11. Development of next generation sequencing panel for UMOD and association with kidney disease.
Bailie C; Kilner J; Maxwell AP; McKnight AJ
PLoS One; 2017; 12(6):e0178321. PubMed ID: 28609449
[TBL] [Abstract][Full Text] [Related]
12. Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction.
Pazik J; Oldak M; Oziębło D; Materkowska DD; Sadowska A; Malejczyk J; Durlik M
BMC Nephrol; 2020 Sep; 21(1):380. PubMed ID: 32873246
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the association between rs12917707 and rs11864909 single nucleotide polymorphisms in the region of the uromoduline gene and chronic kidney disease - a family-based study.
Żywiec J; Kiliś-Pstrusińska K; Tomaszewski M; Grzeszczak W
Ann Agric Environ Med; 2017 Sep; 24(3):464-466. PubMed ID: 28954491
[TBL] [Abstract][Full Text] [Related]
14. Study of Uromodulin Gene Polymorphism in Egyptian Patients with End-Stage Renal Disease.
Abdelsalam M; Motawea M; Kyrillos F; Abdel-Razik A; Zaki MES; Abdel-Wahab A
Saudi J Kidney Dis Transpl; 2021; 32(1):157-162. PubMed ID: 34145125
[TBL] [Abstract][Full Text] [Related]
15. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese.
Cheng W; Zhou X; Zhu L; Shi S; Lv J; Liu L; Zhang H
Nephrol Dial Transplant; 2011 Aug; 26(8):2544-9. PubMed ID: 21245129
[TBL] [Abstract][Full Text] [Related]
17. Association between
Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
[TBL] [Abstract][Full Text] [Related]
18. Functional Effects of SNPs in MYH9 and Risks of Nonsyndromic Orofacial Clefts.
Wang Y; Li D; Xu Y; Ma L; Lu Y; Wang Z; Wang L; Zhang W; Pan Y
J Dent Res; 2018 Apr; 97(4):388-394. PubMed ID: 29207917
[TBL] [Abstract][Full Text] [Related]
19. KIDNEY DISEASE GENETICS AND THE IMPORTANCE OF DIVERSITY IN PRECISION MEDICINE.
Cooke Bailey JN; Wilson S; Brown-Gentry K; Goodloe R; Crawford DC
Pac Symp Biocomput; 2016; 21():285-96. PubMed ID: 26776194
[TBL] [Abstract][Full Text] [Related]
20. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.
Franceschini N; Voruganti VS; Haack K; Almasy L; Laston S; Goring HH; Umans JG; Lee ET; Best LG; Fabsitz RR; MacCluer JW; Howard BV; North KE; Cole SA
Hum Genet; 2010 Mar; 127(3):295-301. PubMed ID: 19921264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
